Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation

PURPOSE: The safety and efficacy of a minimally interrupted novel oral anticoagulant (NOAC) strategy at the time of atrial fibrillation (AF) ablation is uncertain. The purpose of this study was to compare rates of bleeding and thromboembolic events between minimally interrupted NOAC and uninterrupte...

Descripción completa

Detalles Bibliográficos
Autores principales: De Heide, John, Vroegh, Christiaan J., Bhagwandien, Rohit E., Wijchers, Sip A., Szili-Torok, Tamas, Zijlstra, Felix, Lenzen, Mattie J., Yap, S. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292967/
https://www.ncbi.nlm.nih.gov/pubmed/30074120
http://dx.doi.org/10.1007/s10840-018-0417-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292967/
https://www.ncbi.nlm.nih.gov/pubmed/30074120
http://dx.doi.org/10.1007/s10840-018-0417-0

Ejemplares similares